Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 26, 2012 (14 years ago)

Isovue 200 mg/mL PF and 300 mg/mL PF

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA

Recalling firm
New England Compounding Center
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-119-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by New England Compounding Center

All 2012 recalls

Other sterility / contamination recalls from 2012

All sterility / contamination recalls
Class I · High risk

Cyanocobalamin 1000 mcg/ml

Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.

Terminated Sterility / contamination Green Valley Drugs D-322-2013
Class III · Low risk

TORISEL Kit

Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

Terminated Sterility / contamination Pfizer Inc. NDC 0008-1179-01 D-219-2013
Class II · Moderate risk

Nalbuphine HCl Injection

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.

Terminated Sterility / contamination Hospira, Inc. NDC 0409-1467-01 D-096-2013